AC Immune SA (ACIU) — Stock Score Summary

AC Immune SA (ACIU) has a MoatMap StockRank of 7/100 based on Quality (14/100), Value (31/100), and Momentum (41/100) factor scores. The current signal is STRONG SELL. AC Immune is a clinical-stage Swiss biotech focused on neurodegenerative diseases. It has no commercialized products, high cash burn, and fails all quality and moat criteria.

AC Immune SA is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing precision medicines and diagnostics for neurodegenerative diseases, focusing on conditions like Alzheimer's and Parkinson's. The company leverages proprietary technology platforms like Morphomer and SupraAntigen to target misfolded proteins, a key pathological hallmark of these diseases. AC Immune's competitive edge is its specialized R&D in this complex field, aiming to bring innovative solutions to areas of high unmet medical need.

Key Financial Metrics

Price$2.26
Market Cap$299M
P/E (Forward)16.37
Price/Book5.91
Return on Equity-104.8%
Return on Invested Capital-118.0%
Debt/Equity13.65
Gross Margin0.0%
Operating Margin-1321.5%
Revenue Growth13.0%

AC Immune SA operates in the Biotechnology industry, part of the Healthcare sector (Switzerland).

Frequently Asked Questions

What is AC Immune SA’s (ACIU) StockRank?
MoatMap’s StockRank for AC Immune SA (ACIU) is 7/100, with a Strong Sell signal. It is a composite of Quality (14), Value (31), and Momentum (41) factor ranks across MoatMap’s 19,000+ stock universe.
Does AC Immune SA have an economic moat?
AC Immune SA (ACIU) has a Quality factor score of 14/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is AC Immune SA a buy, hold, or sell?
MoatMap’s current signal for AC Immune SA (ACIU) is Strong Sell, based on a StockRank of 7/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is AC Immune SA in?
AC Immune SA (ACIU) operates in the Healthcare sector, specifically the Biotechnology industry (Switzerland).
Browse all ranked stocksACIU deep dive reportAI ChampionsHow we score stocksSense-check another stock